Security Snapshot

Surgery Partners, Inc. - Common Stock, par value $0.01 per share (SGRY) Institutional Ownership

CUSIP: 86881A100

13F Institutional Holders and Ownership History from Q4 2015 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

183

Shares (Excl. Options)

159,165,130

Price

$11.92

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+2,070,904
Value change
+$17,564,437
Number of holders
183
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
130,463,918
SEC-reported price per share
$13.69
Insider filing price
$13.69
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • SGRY - Surgery Partners, Inc. - Common Stock, par value $0.01 per share is tracked under CUSIP 86881A100.
  • 183 institutions reported positions in Q1 2026.
  • 7 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 180 to 183 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $2,423,515,367 to $1,897,226,003.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 183 institutions filings for Q1 2026.

Open SEC evidence

Security key

86881A100

Latest holder period

Q1 2026

13F holders

183

13D/G owners

7

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
7
Security
SGRY
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BCPE Seminole Holdings LP 23% -0.62% $687,963,459 30,055,197 0% BCPE Seminole Holdings II Intermediate, LP 16 Jun 2025
JANUS HENDERSON GROUP PLC 10% +1% $282,111,656 +$1,767,274 13,036,583 +0.63% JANUS HENDERSON GROUP PLC 30 Sep 2025
Pentwater Capital Management LP 9.7% +25% $165,653,950 +$34,753,950 12,655,000 +27% Pentwater Capital Management LP 31 Mar 2026
KING STREET CAPITAL MANAGEMENT, L.P. 7.2% $202,116,085 9,339,930 King Street Capital Management, L.P. 30 Oct 2025
BlackRock, Inc. 4.4% $126,722,839 5,675,004 BlackRock, Inc. 31 Mar 2025
FMR LLC 1.7% -68% $28,686,278 -$56,883,263 2,191,465 -66% FMR LLC 31 Mar 2026
WELLINGTON MANAGEMENT GROUP LLP 0% -93% $4,783 -$156,297,520 217 -100% Wellington Management Group LLP 30 Jun 2025

As of 31 Mar 2026, 183 institutional investors reported holding 159,165,130 shares of Surgery Partners, Inc. - Common Stock, par value $0.01 per share (SGRY). This represents 122% of the company’s total 130,463,918 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
110%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Bain Capital Investors LLC 38% 49,946,972 0% 18% $595,367,906
JANUS HENDERSON GROUP PLC 10% 13,540,385 +0.02% 0.08% $161,400,529
Pentwater Capital Management LP 9.7% 12,655,000 +27% 1.1% $150,847,600
KING STREET CAPITAL MANAGEMENT, L.P. 7.8% 10,229,730 0% 37% $121,938,382
UBS Group AG 7.8% 10,191,781 +31% 0.02% $121,486,029
BlackRock, Inc. 4.3% 5,660,788 -0.53% 0% $67,476,592
DIMENSIONAL FUND ADVISORS LP 4.1% 5,296,411 +7.9% 0.01% $63,130,850
Clearbridge Investments, LLC 3.2% 4,118,056 -2.6% 0.04% $49,087,222
VANGUARD PORTFOLIO MANAGEMENT LLC 2.8% 3,628,431 0% 0% $43,250,898
VANGUARD CAPITAL MANAGEMENT LLC 2.6% 3,430,795 0% 0% $40,895,076
Davidson Kempner Capital Management LP 2.6% 3,336,464 +41% 0.86% $39,770,651
FMR LLC 1.7% 2,191,465 -67% 0% $26,122,264
GEODE CAPITAL MANAGEMENT, LLC 1.5% 2,002,374 +3% 0% $23,872,449
STATE STREET CORP 1.5% 1,953,778 +4.3% 0% $23,289,034
T. Rowe Price Investment Management, Inc. 1.5% 1,949,720 +311% 0.02% $23,241,000
HSBC HOLDINGS PLC 1.5% 1,915,668 -0.82% 0.01% $22,567,082
GLENVIEW CAPITAL MANAGEMENT, LLC 1.4% 1,800,000 -53% 0.58% $21,456,000
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 1.2% 1,589,368 +44% 0% $18,945,266
GOLDMAN SACHS GROUP INC 0.98% 1,280,552 -35% 0% $15,264,180
BANK OF AMERICA CORP /DE/ 0.95% 1,239,982 +98% 0% $14,780,584
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.85% 1,107,250 +12% 0% $13,198,420
LMR Partners LLP 0.84% 1,100,000 +205% 0.12% $13,112,000
Sea Cliff Partners Management, LP 0.8% 1,039,799 +54% 6.4% $12,394,404
MORGAN STANLEY 0.78% 1,012,177 -11% 0% $12,065,151
Man Group plc 0.73% 946,519 +188% 0.02% $11,282,506

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
42
Latest
Q1 2026
Rows shown
1-25 of 42
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 159,165,130 $1,897,226,003 +$17,564,437 $11.92 183
2025 Q4 156,841,358 $2,423,515,367 +$56,378,840 $15.45 180
2025 Q3 151,406,137 $3,276,548,227 +$150,915,327 $21.64 197
2025 Q2 144,278,301 $3,207,216,275 +$96,557,278 $22.23 197
2025 Q1 139,643,559 $3,318,979,664 -$12,576,150 $23.75 204
2024 Q4 141,590,930 $2,997,289,879 +$19,892,991 $21.17 179
2024 Q3 137,923,250 $4,445,824,164 -$93,744,817 $32.24 184
2024 Q2 141,883,973 $3,375,681,923 +$113,712,319 $23.79 176
2024 Q1 136,901,931 $4,083,856,130 +$38,695,342 $29.83 178
2023 Q4 135,040,344 $4,320,033,899 +$5,014,626 $31.99 173
2023 Q3 134,819,136 $3,943,422,688 +$14,620,005 $29.25 164
2023 Q2 132,665,983 $5,968,815,677 +$151,844,535 $44.99 166
2023 Q1 130,043,383 $4,482,475,885 +$52,737,369 $34.47 151
2022 Q4 128,874,004 $3,590,376,282 +$982,835,667 $27.86 158
2022 Q3 93,927,789 $2,198,657,234 +$8,876,623 $23.40 130
2022 Q2 92,368,659 $2,671,774,444 +$36,680,603 $28.92 131
2022 Q1 90,688,899 $4,990,971,268 +$127,182,466 $55.05 142
2021 Q4 88,382,048 $4,720,313,294 +$406,797,201 $53.41 133
2021 Q3 81,052,523 $3,431,762,979 +$5,393,826 $42.34 133
2021 Q2 80,625,719 $5,370,104,650 +$1,564,829,794 $66.62 134
2021 Q1 57,619,712 $2,550,066,106 +$478,555,256 $44.26 119
2020 Q4 47,610,695 $1,381,528,968 -$18,908,903 $29.01 114
2020 Q3 47,513,254 $1,040,400,198 +$2,262,549 $21.90 99
2020 Q2 48,235,131 $557,972,424 +$27,624,491 $11.57 97
2020 Q1 46,997,441 $306,469,825 -$2,816,295 $6.53 83
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .